Neuroendocrine Tumors

Known as: Neuroendocrine neoplasia, Neuroendocrine tumor NOS, Neuroendocrine Tumors [Disease/Finding] 
A tumor that forms from cells that release hormones in response to a signal from the nervous system. Some examples of neuroendocrine tumors are… (More)
National Institutes of Health

Related topics

Related topics

15 relations
Blood supply aspectsEndocrine systemEpithelial CellsEpithelium
(More)

Narrower (2)

Gastro-enteropancreatic neuroendocrine tumorPancreatic islet cell tumors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Martyn E. Caplin, D.M., Marianne Pavel, M.D., Jarosław B. Ć wikła, M.D., Ph.D., Alexandria T. Phan, M.D., Markus Raderer, M.D… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Everolimus for advanced pancreatic neuroendocrine tumors.
BACKGROUND Everolimus, an oral inhibitor of mammalian target of rapamycin (mTOR), has shown antitumor activity in patients with… (More)
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
BACKGROUND The multitargeted tyrosine kinase inhibitor sunitinib has shown activity against pancreatic neuroendocrine tumors in… (More)
  • table 1
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
Pancreatic neuroendocrine tumors (PanNETs) are a rare but clinically important form of pancreatic neoplasia. To explore the… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from…
PURPOSE Somatostatin analogs are indicated for symptom control in patients with gastroenteropancreatic neuroendocrine tumors… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2008
Review
2008
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.
PURPOSE Neuroendocrine tumors (NETs) are considered rare tumors and can produce a variety of hormones. In this study, we examined… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2008
Review
2008
Gastroenteropancreatic neuroendocrine tumours.
Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are fairly rare neoplasms that present many clinical challenges. They… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2006
Review
2006
Imaging of neuroendocrine tumors.
Neuroendocrine tumors (NETs) are rare neoplasms, which are characterized by the presence of neuroamine uptake mechanisms and/or… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
The need for standards in the management of patients with endocrine tumors of the digestive system prompted the European… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2004
Review
2004
The diagnosis and medical management of advanced neuroendocrine tumors.
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endocrine glands such as the… (More)
Is this relevant?